Literature DB >> 31713760

Differential expression of STAT3 gene and its regulatory long non-coding RNAs, namely lnc-DC and THRIL, in two eastern Iranian ethnicities with multiple sclerosis.

Majid Pahlevan Kakhki1,2, Nahid Rakhshi3, Mohammad Sajad Emami Aleagha4, Mahla Abdari5, Asieh Alikhah6, Ghazal Safarian7, Mehrdad Behmanesh6, Abbas Nikravesh8.   

Abstract

OBJECTIVE: Genome-wide association studies (GWASs) revealed that variants of STAT3 are associated with multiple sclerosis (MS) risk. There are several studies showing the effect of ethnicity and genetic background on the characteristics of MS. Here, we aimed to investigate STAT3 gene expression status along with its two regulatory long non-coding RNAs, lnc-DC and THRIL, in order to compare the expression of these target genes among two different ethnicities in the east of Iran.
METHODS: A case-control study was performed between two groups of MS populations in east of Iran. We recruited individuals with Kurdish ethnicity from North Khorasan and Sistani ethnicity from southeast of Iran. The peripheral blood mononuclear cells were obtained from all participants, and total RNA was extracted. The gene expression of the selected genes was evaluated by qPCR.
RESULTS: The expression of THRIL in North Khorasan MS patients was significantly higher than controls (P = 0.03). The results of simultaneous analysis of expression of the target genes (STAT3, THRIL, and lnc-DC) in both ethnic groups failed to show any significant difference between the MS patients and controls (P > 0.05). In addition, the expression of STAT3 and THRIL genes in Sistani MS patients was statistically meaningful lower than healthy controls (P < 0.05).
CONCLUSION: To our knowledge, this is the first study that compared the expression of the STAT3 gene and its regulatory molecules between two ethnic groups of Iranian MS patients. We suggested that STAT3 and its associated molecules might be differentially expressed and regulated in MS patients with different genetic background.

Entities:  

Keywords:  Long non-coding RNA; Multiple sclerosis; STAT3; THRIL; lnc-DC

Year:  2019        PMID: 31713760     DOI: 10.1007/s10072-019-04092-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  36 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Series introduction. JAK-STAT signaling in human disease.

Authors:  Christian W Schindler
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 3.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

4.  Response to interferon beta-1a treatment in African American multiple sclerosis patients.

Authors:  Bruce A C Cree; Ahmad Al-Sabbagh; Randy Bennett; Douglas Goodin
Journal:  Arch Neurol       Date:  2005-11

Review 5.  Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis.

Authors:  Peter Rieckmann; Mathias Mäurer
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

6.  The expression of lnc-IL-7R long non-coding RNA dramatically correlated with soluble and membrane-bound isoforms of IL-7Ra gene in multiple sclerosis patients.

Authors:  Parinaz Bina; Majid Pahlevan Kakhki; Mohammad Ali Sahraian; Mehrdad Behmanesh
Journal:  Neurosci Lett       Date:  2017-02-04       Impact factor: 3.046

7.  Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.

Authors:  Timothy J Harris; Joseph F Grosso; Hung-Rong Yen; Hong Xin; Marcin Kortylewski; Emilia Albesiano; Edward L Hipkiss; Derese Getnet; Monica V Goldberg; Charles H Maris; Franck Housseau; Hua Yu; Drew M Pardoll; Charles G Drake
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

8.  Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.

Authors:  Yi Li; Colin de Haar; Min Chen; Jasper Deuring; Monique M Gerrits; Ron Smits; Bing Xia; Ernst J Kuipers; C Janneke van der Woude
Journal:  Gut       Date:  2009-11-18       Impact factor: 23.059

Review 9.  Long noncoding RNA: an emerging paradigm of cancer research.

Authors:  Man-Tang Qiu; Jing-Wen Hu; Rong Yin; Lin Xu
Journal:  Tumour Biol       Date:  2013-01-29

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  3 in total

1.  Long Non-coding RNAs and mRNAs Expression Profiles of Monocyte-Derived Dendritic Cells From PBMCs in AR.

Authors:  Yumei Zhou; Xuemei Chen; Yanfei Zheng; Rongmin Shen; Shuxian Sun; Fei Yang; Jiayu Min; Lei Bao; Yan Zhang; Xiaoshan Zhao; Ji Wang; Qi Wang
Journal:  Front Cell Dev Biol       Date:  2021-02-09

2.  Expression of SOX2OT, DANCR and TINCR long non‑coding RNAs in papillary thyroid cancer and its effects on clinicopathological features.

Authors:  Fadime Mutlu Icduygu; Egemen Akgun; Demet Sengul; Asuman Ozgoz; Ebru Alp
Journal:  Mol Med Rep       Date:  2022-02-11       Impact factor: 2.952

Review 3.  Long Non-Coding RNAs, Novel Offenders or Guardians in Multiple Sclerosis: A Scoping Review.

Authors:  Abbas Jalaiei; Mohammad Reza Asadi; Hani Sabaie; Hossein Dehghani; Jalal Gharesouran; Bashdar Mahmud Hussen; Mohammad Taheri; Soudeh Ghafouri-Fard; Maryam Rezazadeh
Journal:  Front Immunol       Date:  2021-12-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.